Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles-Reference-Cited by-同舟云学术

Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles

Published:2003-10 Issue:2 Volume:170 Page:315-323
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Wang Tzung-Dau,Chen Wen-Jone,Lin Jong-Wei,Cheng Ching-Chih,Chen Ming-Fong,Lee Yuan-Teh

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice;Vicari;Arch. Fam. Med.,2000

2. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome;Grundy;Am. J. Cardiol.,1998

3. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population;Wang;Am. J. Cardiol.,2001

4. Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia;Stein;Arterioscler. Thromb. Vasc. Biol.,2001

5. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment;Manninen;Circulation,1992

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Bezafibrate, a PPARα Activator, on Acute and Subacute Inflammation in Male Wistar Rats;Journal of Pharmacology and Pharmacotherapeutics;2023-03

2. Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications;Current Medicinal Chemistry;2020-03-16

3. Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention;Current Medicinal Chemistry;2019-05-21

4. Association of serum calprotectin (S100A8/A9) concentrations and idiopathic hyperlipidemia in Miniature Schnauzers;Journal of Veterinary Internal Medicine;2019-02-20

5. Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2018-04